This is the authors' abstract. We don't add key points for this paper.
To calculate effect size (ES), number-needed-to-treat (NNT), and number-needed-to-harm (NNH), statistical representations of efficacy and tolerability that may assist clinicians' treatment decisions, from two solriamfetol registrational studies in excessive daytime sleepiness (EDS) in adults with narcolepsy or obstructive sleep apnea (OSA).
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Chepke et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: